Epigenetic Silencing Of Cyclooxygenase-2 Affects Clinical Outcome In Gastric Cancer

Abstract

The present invention discloses methods of using the methylation status of the COX-2 gene promoter region as a biomarker for a gastric cancer patient to determine a prognosis and a treatment regimen, and to monitor the progress of a treatment regimen.


Claims
Download PDF
Document Preview
Document History
  • Publication: Oct 16, 2012
  • Application: Dec 14, 2009
    US US 63761009 A
  • Priority: Dec 14, 2009
    US US 63761009 A
  • Priority: Jun 13, 2008
    US US 2008/0067027 W
  • Priority: Jun 13, 2007
    US US 94381207 P

Download Citation


Sign in to the Lens

Feedback